Park Ha Biological Technology Regains Nasdaq Compliance, Averting Delisting Risk
BYAH is trading near its 52-week low of $1.4 (5.7% above the low) on light trading volume (0.1× avg).
Summary
Park Ha Biological Technology announced it has regained compliance with Nasdaq's minimum bid price requirement, effectively resolving the delisting threat.
Key Events · Corporate Governance and Compliance · BYAH
-
Nasdaq Compliance Regained
The company received notification from Nasdaq that it has regained compliance with the minimum bid price requirement of $1.00 per share, having maintained a closing bid price at or above this level for 10 consecutive business days from February 20 through March 5, 2026.
-
Delisting Threat Removed
This resolution closes the matter regarding the potential delisting from the Nasdaq Capital Market due to the previous non-compliance with the minimum bid price rule.
Analysis · BYAH · Industrial Applications And Services
This filing is highly significant for Park Ha Biological Technology, a micro-cap company. Regaining compliance with Nasdaq's minimum bid price requirement removes an immediate and critical threat of delisting. Delisting would severely impact the company's ability to raise capital, reduce liquidity for shareholders, and significantly erode investor confidence. The resolution of this compliance issue provides stability and removes a major overhang, which is a positive development for the company's operational continuity and market perception.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 36.1% of the 1753 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BYAH was trading at $1.48 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.2M. The 52-week trading range was $1.40 to $2,074.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.